Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
56.04
1.05 (1.91%)
At close: Aug 15, 2025, 3:59 PM
56.07
0.05%
After-hours: Aug 15, 2025, 04:34 PM EDT
Protagonist Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 28.32M | 170.64M | 4.67M | 4.17M | 254.95M | 60M | n/a | n/a | n/a | n/a | n/a | 859K | 25.72M | 8.62M | 10.29M | 2.27M | 6.19M |
Cost of Revenue | n/a | n/a | n/a | n/a | 892K | 820K | 832K | 827K | 821K | 832K | 256K | 853K | 843K | 833K | 819K | n/a | n/a | n/a |
Gross Profit | n/a | 28.32M | 170.03M | 4.67M | 3.27M | 254.13M | 59.17M | -827K | -821K | -832K | -256K | -853K | 16K | 24.89M | 7.8M | 10.29M | 2.27M | 6.19M |
Operating Income | -42.04M | -19.31M | 126.78M | -41.45M | -38.79M | 206.31M | 23.05M | -38.33M | -42.35M | -36.02M | -36.52M | -32.3M | -41.44M | -21.11M | -37.02M | -33.93M | -30.88M | -24.02M |
Interest Income | 7.41M | 7.57M | 6.85M | 7.68M | 7.4M | 4.38M | 4.24M | 4.25M | 3.91M | 2.49M | 2.25M | 1.16M | 484K | 168K | 122K | 122K | 97K | 102K |
Pretax Income | -34.6M | -11.65M | 133.66M | -33.63M | -31.29M | 210.67M | 27.34M | -34.1M | -38.46M | -33.73M | -34.19M | -31.23M | -41.04M | -20.93M | -36.91M | -33.8M | -30.84M | -24M |
Net Income | -34.77M | -11.65M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.1M | -38.46M | -31.43M | -31.29M | -30.16M | -40.63M | -20.75M | -36.91M | -33.8M | -30.84M | -24M |
Selling & General & Admin | 10.55M | 11.74M | 8.95M | 10.16M | 8.55M | 14.09M | 8.05M | 7.66M | 9.17M | 8.61M | 6.63M | 6.9M | 7.69M | 10.52M | 7.26M | 7.26M | 6.71M | 5.96M |
Research & Development | 37.04M | 35.89M | 34.9M | 35.97M | 33.52M | 33.73M | 28.9M | 30.66M | 33.18M | 27.42M | 29.88M | 25.4M | 34.61M | 36.32M | 38.37M | 36.96M | 26.43M | 24.25M |
Other Expenses | n/a | n/a | n/a | n/a | 97K | -19K | 44K | -31K | -19K | -195K | 71K | -86K | -78K | 13K | -13K | n/a | -57K | -79K |
Operating Expenses | 47.59M | 47.63M | 43.86M | 46.13M | 42.07M | 47.82M | 36.95M | 38.33M | 42.35M | 36.02M | 36.52M | 32.3M | 42.3M | 46.83M | 45.63M | 44.21M | 33.15M | 30.21M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -892K | -820K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 47.63M | 43.86M | 46.13M | 42.96M | 48.64M | 36.95M | 38.33M | 42.35M | 36.02M | 36.52M | 32.3M | 42.3M | 46.83M | 45.63M | 44.21M | 33.15M | 30.21M |
Income Tax Expense | 172K | n/a | 1.99M | -420K | -676K | 3.33M | n/a | n/a | n/a | -2.3M | -2.91M | -1.07M | -406K | -181K | n/a | 122K | -57K | -79K |
Shares Outstanding (Basic) | 63.51M | 62.96M | 62.33M | 61.77M | 61.31M | 60.86M | 60.39M | 59.18M | 56.78M | 50.57M | 49.26M | 48.8M | 48.85M | 48.67M | 48.15M | 47.99M | 44.86M | 44.22M |
Shares Outstanding (Diluted) | 63.51M | 62.96M | 66.41M | 61.77M | 61.31M | 63.6M | 61.8M | 59.18M | 56.78M | 50.57M | 49.26M | 49.11M | 49.05M | 48.75M | 48.15M | 47.99M | 44.86M | 44.22M |
EPS (Basic) | -0.55 | -0.19 | 2.11 | -0.54 | -0.5 | 3.41 | 0.45 | -0.58 | -0.68 | -0.62 | -0.64 | -0.62 | -0.83 | -0.43 | -0.77 | -0.7 | -0.69 | -0.54 |
EPS (Diluted) | -0.55 | -0.19 | 1.98 | -0.54 | -0.5 | 3.26 | 0.44 | -0.58 | -0.68 | -0.62 | -0.64 | -0.61 | -0.83 | -0.43 | -0.77 | -0.7 | -0.69 | -0.54 |
EBITDA | -42.04M | -19.07M | 127.32M | -40.81M | -38.79M | 207.13M | 23.88M | -38.33M | -42.35M | -35.19M | -33.94M | -31.45M | -40.19M | -20.1M | -36.99M | -33.22M | -30.25M | -23.4M |
EBIT | -42.04M | -19.31M | 126.78M | -41.45M | -38.79M | 206.31M | 23.05M | -38.33M | -42.35M | -36.02M | -34.19M | -32.3M | -41.44M | -21.11M | -36.91M | -33.93M | -30.88M | -24.02M |
Depreciation & Amortization | n/a | 239K | 536K | 647K | 892K | 820K | 832K | 827K | 821K | 832K | 256K | 853K | 843K | 833K | 819K | 704K | 628K | 624K |